Showing results (1-10 of 180) with videos related to
Sort By:
Pageof 18
Journal of Leukocyte Biology|April 16, 2014
At the bedside: adoptive cell therapy for melanoma-clinical developmentJeffrey S WeberAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|September 21, 2018
Challenging Cases: Management of Immune-Related ToxicityJeffrey S WeberMelanoma Research|October 3, 2006
The clinical utility of cytotoxic T lymphocyte antigen 4 abrogation by human antibodiesJeffrey S WeberAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2017
Biomarkers for Checkpoint InhibitionJeffrey S WeberThe Journal of Investigative Dermatology|November 11, 2008
Tumor evasion may occur via expression of regulatory molecules: a case for CTLA-4 in melanomaJeffrey S WeberAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
Practical management of immune-related adverse events from immune checkpoint protein antibodies for the oncologistJeffrey S WeberCurrent Opinion in Investigational Drugs (London, England : 2000)|July 2, 2002
Review of the clinical experience with 5-azacytidine and 5-aza-2'-deoxycytidine in solid tumorsAna Aparicio, Jeffrey S WeberCancer Immunology, Immunotherapy : CII|February 19, 2017
PD-1 and PD-L1 antibodies in cancer: current status and future directionsArjun Vasant Balar, Jeffrey S WeberClinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 26, 2022
Intratumoral Therapy to Make a "Cold" Tumor "Hot": The Jury Is Still OutSalman R Punekar, Jeffrey S WeberPageof 18